Drug Discovery

New Target Found for Triple-Negative Breast Cancer
Research & Development New Target Found for Triple-Negative Breast Cancer

For the thousands diagnosed each year with triple-negative breast cancer, the treatment path has often been a brutal journey defined by the blunt instrument of chemotherapy, but a groundbreaking discovery is now illuminating a far more precise and strategic path forward. This particularly

First Topical CRISPR Therapy Treats Genetic Skin Disease
Research & Development First Topical CRISPR Therapy Treats Genetic Skin Disease

For individuals living with debilitating genetic skin disorders, effective treatments have remained elusive, often limited to managing symptoms rather than addressing the root cause encoded in their DNA. A groundbreaking development from researchers at the University of British Columbia and the

New Therapies Target Cancer's Amino Acid Metabolism
Research & Development New Therapies Target Cancer's Amino Acid Metabolism

Recent breakthroughs are fundamentally recasting our understanding of cancer, shifting the focus from a disease of uncontrolled cell division to one characterized by a profoundly altered and ravenous metabolism. At the heart of this new perspective is the discovery that malignant cells harbor a

New Trials Are Reshaping Bladder Cancer Care
Research & Development New Trials Are Reshaping Bladder Cancer Care

The treatment paradigm for bladder cancer is undergoing a seismic shift, as a new wave of clinical research moves beyond traditional protocols to pioneer a more integrated, intelligent, and immune-focused approach to care. This evolution is not merely about refining existing methods but about

FDA Partially Lifts Hold on Intellia CRISPR Trial
Research & Development FDA Partially Lifts Hold on Intellia CRISPR Trial

Today we’re joined by Ivan Kairatov, a biopharma expert with deep experience in drug development and the intricate dance between innovation, regulation, and market perception. We'll be dissecting the recent developments with Intellia Therapeutics, a pioneer in CRISPR gene editing. The company has

What Is the Double-Edged Sword of Cancer Fibroblasts?
Research & Development What Is the Double-Edged Sword of Cancer Fibroblasts?

Within the intricate ecosystem of a tumor, cancer cells are far from acting alone; they are surrounded by a complex network of supporting cells that form the tumor microenvironment. Among these collaborators, cancer-associated fibroblasts (CAFs) have emerged as particularly influential players.

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later